Stock 600062 CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News China Resources Double-Crane Pharmaceutical Co.,Ltd.

Equities

600062

CNE000000Q94

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
18.28 CNY -1.08% Intraday chart for China Resources Double-Crane Pharmaceutical Co.,Ltd. -5.63% -1.72%
Jul. 03 Double-Crane Pharmaceutical Unit Gets China Nod for Influenza Drug MT
Jun. 28 CR Double-Crane Pharmaceutical Registers Antibiotic, Ulcer Medications in China MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Double-Crane Pharmaceutical Unit Gets China Nod for Influenza Drug
MT
CR Double-Crane Pharmaceutical Registers Antibiotic, Ulcer Medications in China
MT
CR Double-Crane Pharmaceutical Gets Certificate to Market Low-Calcium Dialysis Solution
MT
CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection
MT
CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug
MT
CR Double-Crane Pharmaceutical's Unit Gets Nod for Lidocaine Hydrochloride Injection
MT
CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2%
MT
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication
MT
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CR Double-Crane Pharmaceutical Gets Nod to Trial Semaglutide Injection
MT
CR Double-Crane Pharma Unit Receives Approval for Epilepsy Drug
MT
CR Double-Crane Pharma's 2023 Profit Jumps 13%, Operating Income Climbs 6%
MT
China Resources Double-Crane Pharmaceutical Co.,Ltd. Proposes Cash Dividend
CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CR Double-crane Pharmaceutical Gets Nod to Market Doxazosin Mesylate Tablets
MT
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire China Resources Zizhu Pharmaceutical Co., Ltd. from Beijing Pharmaceutical Group Co., Ltd. for CNY3.1 billion.
CI
CR Double-Crane Pharma Gets Nod for Apixaban Tablets; Unit's Clozapine Orally Disintegrating Tablets Gets Greenlight for Proposed Amendments
MT
CR Double-Crane Pharma's Unit Gets Nod to Market Lithium Carbonate Drug Ingredient
MT
CR Double-Crane Pharmaceutical's Unit Gets Nod to Raise Strength of Viagra Drug
MT
China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600062 Stock
  4. News China Resources Double-Crane Pharmaceutical Co.,Ltd.